Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Varenicline: new treatment with efficacy in smoking cessation.Drugs Today (Barc). 2007; 43: 65-75
- Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2012; 4: CD006103
- Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary.Respir Care. 2008; 53: 1217-1222
- Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.Arch Intern Med. 2011; 171: 770-777
Potential Competing Interests: Dr Jiménez-Ruiz has consulted for GSK, Pfizer and Johnson & Johnson.